Emily Kanwischer
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Arkansas Children's Research Institute (2023)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Emily Kanwischer's research focuses on the discovery of novel therapeutic agents, particularly for non-small cell lung cancer. Her work involves the development of quinazoline-based dual inhibitors targeting RET and Aurora B kinases. This research aims to identify compounds with potential antitumor properties. Kanwischer has also contributed to the field of virology, with a publication detailing the sequencing of the SARS-CoV-2 Lambda variant found in Arkansas. Her scholarship metrics indicate a total of two publications, with her most recent publication dating to 2026, signifying recent activity in her research endeavors.
Metrics
- Publications: 2
Selected Publications
-
Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer (2026)
Collaboration Network
Top Collaborators
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
Similar Researchers
Based on overlapping research topics